Search Result "Secukinumab"
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report
Journal: Current Drug Safety
Volume: 15 Issue: 1 Year: 2020 Page: 69-72
Author(s): Stefano Dastoli,Luigi Francesco Iannone,Luigi Bennardo,Martina Silvestri,Caterina Palleria,Steven Paul Nisticò,Giovambattista De Sarro,Emilio Russo
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways
Journal: Current Pharmaceutical Biotechnology
Volume: 18 Issue: 12 Year: 2017 Page: 964-978
Author(s): Elisa Molinelli,Anna Campanati,Valerio Brisigotti,Annamaria Offidani
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis
Journal: Current Pharmaceutical Biotechnology
Volume: 22 Issue: 1 Year: 2021 Page: 7-31
Author(s): Giulia Radi,Anna Campanati,Federico Diotallevi,Tommaso Bianchelli,Annamaria Offidani
IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System
Journal: Current Drug Targets
Volume: 17 Issue: 16 Year: 2016 Page: 1882-1893
Author(s): Frank Kolbinger,Christine Huppertz,Anis Mir,Franco Di Padova
An Update of the Published Reports on Biologics Use for Psoriasis and the Reimbursement Status in Asia-Pacific Region
Journal: Current Rheumatology Reviews
Volume: 8 Issue: 3 Year: 2012 Page: 227-234
Author(s): Tsen-Fang Tsai,Ting-Yu Yeh
The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 11 Issue: 2 Year: 2012 Page: 159-168
Author(s): Eric Toussirot
Currently Used Biologic Agents in the Management of Behcetâs Syndrome
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 16 Year: 2015 Page: 1976-1985
Author(s): Caner Saygin,Didem Uzunaslan,Gulen Hatemi
Biologics in Inflammatory and Immunomediated Arthritis
Journal: Current Pharmaceutical Biotechnology
Volume: 18 Issue: 12 Year: 2017 Page: 989-1007
Author(s): Michele M. Luchetti,Devis Benfaremo,Armando Gabrielli
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors
Journal: Current Pharmaceutical Biotechnology
Volume: 18 Issue: 12 Year: 2017 Page: 945-963
Author(s): Anna Campanati,Elisa Molinelli,Valerio Brisigotti,Annamaria Offidani
COVID-19 in Patients with Systemic Inflammatory Diseases: Impact onDisease Activity
Journal: Current Rheumatology Reviews
Volume: 19 Issue: 3 Year: 2023 Page: 330-335
Author(s):